Lipid management and control of other coronary risk factors in the postmenopausal woman.
This review identifies coronary heart disease (CHD) as the leading cause of mortality among postmenopausal women and highlights the well-documented problem of underrecognition and undertreatment of women who are at risk for or who already have CHD. This undertreatment encompasses both preventive care (i.e., drug treatment for lipid management) and more invasive treatments (e.g., revascularization procedures). Preventive interventions to reduce dyslipidemia and control other coronary risk factors can lessen CHD mortality and morbidity in the postmenopausal woman.
Wenger
N K
NK
Department of Medicine, Emory University School of Medicine, Grady Memorial Hospital, and Emory Heart and Vascular Center, Atlanta, Georgia 30303, USA.
D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors